國立虎尾科技大學 |

ACEi and ARBS in Hypertension and Heart Failure

Record Type:	Language materials, printed : Monograph/item
Title/Author:	ACEi and ARBS in Hypertension and Heart Failure/ edited by Pasquale Perrone Filardi.
other author:	Perrone Filardi, Pasquale.
Description:	X, 150 p. 19 illus., 13 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cardiology. -
Online resource:	https://doi.org/10.1007/978-3-319-09788-6
ISBN:	9783319097886

ACEi and ARBS in Hypertension and Heart Failure
ACEi and ARBS in Hypertension and Heart Failure[electronic resource] /edited by Pasquale Perrone Filardi. - 1st ed. 2015. - X, 150 p. 19 illus., 13 illus. in color.online resource. - Current Cardiovascular Therapy ;5. - Current Cardiovascular Therapy ;7.

Pathogenetic mechanisms of RAS involvement in cardiovascular diseases -- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.- Renin angiotensin system antagonism in heart failure -- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients -- Target organ damage and RAS blockade.

This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.

ISBN: 9783319097886

Standard No.: 10.1007/978-3-319-09788-6doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

ACEi and ARBS in Hypertension and Heart Failure
LDR:02680nam a22003975i 4500 001 967967
003 DE-He213
005 20200701171108.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319097886 $9 978-3-319-09788-6
024 7 $a 10.1007/978-3-319-09788-6 $2 doi
035 $a 978-3-319-09788-6
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a ACEi and ARBS in Hypertension and Heart Failure $h [electronic resource] / $c edited by Pasquale Perrone Filardi.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a X, 150 p. 19 illus., 13 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Cardiovascular Therapy ; $v 5
505 0 $a Pathogenetic mechanisms of RAS involvement in cardiovascular diseases -- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.- Renin angiotensin system antagonism in heart failure -- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients -- Target organ damage and RAS blockade.
520 $a This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
650 0 $a Cardiology. $3 593957
650 0 $a Pharmacotherapy. $3 973587
700 1 $a Perrone Filardi, Pasquale. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1063596
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319097879
776 0 8 $i Printed edition: $z 9783319097893
830 0 $a Current Cardiovascular Therapy ; $v 7 $3 1254793
856 4 0 $u https://doi.org/10.1007/978-3-319-09788-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)